Leadership
Kristen is an Immunologist with extensive experience supporting early discovery efforts, identification and evaluation of lead clinical candidates, first-in-human studies and late-stage clinical trials. She was a member of the Receptos team (and later Celgene) that developed Zeposia® for the treatment of Relapsing MS, UC, and CD. She has also worked on clinical and discovery stage programs in Pulmonary Arterial Hypertension, Asthma, Psoriasis, RA, and several oncology programs. Kristen completed her postdoctoral work in Immunology at The Scripps Research Institute, earned her PhD in Biomedical Sciences from the University of California, San Diego, and her BS in Biochemistry from the University of Arizona.